GenScript Supported Nasal Spray Development for COVID-19 Protection with GMP-grade Antibodies and Subsequently Planned for Long-Term Collaboration with Biogenexis

SINGAPORE, Nov. 1, 2022 /PRNewswire/ — GenScript Biotech Corporation (“GenScript”, Stock Code: 1548.HK), a leading global biotechnology company supported Chulalongkorn University, a research-intensive university in Thailand in developing human anti-SARS-CoV-2 antibodies with antibody production and characterization services. The antibodies were…

Hikma launches RYALTRIS™ seasonal allergic rhinitis nasal spray in the US

RYALTRIS™ is the only fixed-dose combination therapy that provides relief for both nasal and ocular symptoms of seasonal allergic rhinitis in one easy-to-use nasal spray. 60 million Americans suffer from allergic rhinitis and allergic conjunctivitis yet approximately 8.5 million are…

Glenmark Pharmaceuticals and SaNOtize Announce Peer Reviewed Publication of Its Phase 3 Clinical Trials on SaNOtize’s Novel Nitric Oxide Nasal Spray for COVID-19 in Lancet Journal

–  The Lancet Regional Health Southeast Asia publishes the successful phase 3 clinical trial results of Nitric Oxide Nasal Spray. –  Phase 3 trial of Nitric Oxide Nasal Spray administered to adult COVID-19 patients in India met the key endpoints…

Ambee joins NASA’s Plankton, Aerosol, Cloud, ocean Ecosystem (PACE) mission

BANGALORE, India, June 6, 2022 /PRNewswire/ — Datair Technology Pvt Ltd (Ambee), a global platform for hyperlocal and geospatial datasets on air quality, weather, pollen, soil, water vapor, fire, and more, has joined NASA’s PACE Mission as an early adopter. PACE…

SciSparc to Collaborate with Polyrizon for Brain Targeting Using Intranasal Hydrogel Systems

SciSparc will use its SCI-160 technology platform for treating pain in combination with Polyrizons‘ Trap and TargetTM technology TEL AVIV, Israel, May 31, 2022 (GLOBE NEWSWIRE) — SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development…

Xlear Teams Up With Dr. Ferrer BioPharma to Bring a Better User Experience to Nasal Hygiene

Business Wire India Today Xlear announced a new partnership with Dr. Ferrer BioPharma (DFBP), which will make Xlear nasal spray the first nasal hygiene tool to deploy the GentleMist nozzle—the next generation nasal spray technology that research shows achieves better…

NASA Selects SES Government Solutions to Support Near-Earth Communications

Business Wire India SES Government Solutions (SES GS), a wholly-owned subsidiary of SES, in partnership with Planet Labs PBC (Planet), has been awarded a Funded Space Act Agreement from NASA’s Communications Services Project (CSP) to support the development and demonstration…

Topcoder Challenge Finds Two New Comets For NASA

Business Wire India Topcoder, a Wipro company, announced today that the Comet Detection Marathon Match Challenge, conducted on behalf of NASA SOHO/ESA to develop artificial intelligence and machine learning (AI/ML) algorithms capable of detecting comets that reflect minimal light, resulted…

Glenmark Specialty S.A. and Lotus International Pte. Ltd. enter into Exclusive Licensing Agreement for commercializing Ryaltris™ Nasal Spray in Singapore, Hong Kong and Vietnam

Under the terms of the agreement, Glenmark will be responsible for the manufacture and supply of Ryaltris™, while Lotus International Pte. Ltd. will be responsible for the commercialization of Ryaltris™ (subject to receipt of regulatory approvals) across these markets. Glenmark…

Medlab (ASX:MDC) receives Government grant to apply NanoCelle® to an RNA nasal vaccine in collaboration with University of NSW (UNSW) and Macquarie University (MQ) to fight COVID-19 future potential epidemics

NSW Government grant received on 23rd December 2021 to develop a “no-jab” vaccine solution Medlab collaborates with UNSW and MQ University (two leading global academic and R&D institutions) This NanoCelle® non-invasive nasal delivered vaccine is considered a “first in class”…